We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GRASSLEY LETTER: FDA MANAGERS STIFLING ANTIDEPRESSANT PROBE
GRASSLEY LETTER: FDA MANAGERS STIFLING ANTIDEPRESSANT PROBE
June 10, 2004
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is alleging his investigation into allegations the FDA withheld information about a possible link between antidepressant use and suicide in children is being thwarted by FDA managers.